ORIGINAL RESEARCH article

Front. Pediatr., 03 April 2025

Sec. Neonatology

Volume 13 - 2025 | https://doi.org/10.3389/fped.2025.1568891

Early successful weaning from continuous positive airway pressure in infants <32 weeks of gestation: predictors of success


Lisa Marie Bünte,
Lisa Marie Bünte1,2*Christina WaldenChristina Walden3Jennifer SchlechtJennifer Schlecht4Benedikt BublBenedikt Bubl1Mircea-Horia Popa-TodirenchiMircea-Horia Popa-Todirenchi1Susanne TippmannSusanne Tippmann3Julia WinterJulia Winter3Eva Mildenberger,&#x;Eva Mildenberger3,†Andr Kidszun,,&#x;
André Kidszun1,3,†
  • 1Division of Neonatology, Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
  • 2Graduate School for Health Sciences, University of Bern, Bern, Switzerland
  • 3Division of Neonatology, Center for Pediatric and Adolescent Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany
  • 4Division of Pediatric Epidemiology, Institute for Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany

Aim: To identify demographic and clinical variables predictive of early successful weaning in preterm infants weaned off continuous positive airway pressure (CPAP).

Methods: Single-center retrospective analysis of preterm infants < 32 0/7 weeks gestational age (GA) weaned off CPAP according to a standardized protocol April 2013–March 2017. Infants were categorized into (1) early successfully weaned (Early-W) if weaned at the first attempt and (2) delayed weaned (Delayed-W) if more than one attempt was necessary. Potential predictor variables were predefined. Association with Early-W was analyzed by multivariable logistic regression with model selection using the Akaike information criterion (AIC). Model performance was evaluated using the area under the receiver operating characteristic (ROC-AUC).

Results: 145 infants [79 (54.5%) were Early-W and 66 (45.5%) Delayed-W] with complete data sets were included in the analysis. A model of higher GA [odds ratio (OR) 1.66; 95% confidence interval (CI) 1.39, 2.03; p < 0.001], present patent ductus arteriosus (PDA) (OR 0.41, 95% CI 0.16, 1.04; p = 0.062) and higher median respiratory rate (RR) in the previous 12 h (OR 0.36; 95% CI 0.16, 0.74; p = 0.008) best predicted Early-W (ROC-AUC: 0.841).

Conclusion: This study identified GA, PDA and median RR to predict early successful weaning in preterm infants weaned off CPAP. The predictive value of median RR in the 12 h prior to CPAP cessation is considered a novelty requiring further prospective investigation, with RR being a clinical parameter commonly employed in routine practice and practical for everyday application.

1 Introduction

Continuous positive airway pressure (CPAP) is the first-line treatment for respiratory distress syndrome (RDS) in most preterm infants (1, 2).

Initiation of CPAP in preterm infants with RDS has undergone extensive research, but the optimal way and time point of discontinuing CPAP remain a topic of debate, lacking sufficient evidence (38). Identifying the optimal time point for CPAP cessation in this clinical setting is crucial as both premature weaning and prolonged use of CPAP are associated with unfavorable outcomes (5). Premature cessation of CPAP therapy may lead to loss of functional residual capacity (FRC) and atelectasis, which could require subsequent respiratory support and recruitment effort (9). Repeated cycles of atelectasis and recruitment may promote atelectotrauma, potentially contributing to the development of chronic lung disease (10). At the same time, CPAP is associated with unfavorable outcomes such as pneumothorax, nasal trauma, discomfort, feeding and sleep problems (1115). Hence, CPAP duration should be limited. To help guide clinicians facing this balancing act, there is a need to establish specific demographic and clinical variables predictive of an infant's readiness to successfully cease CPAP (5). Some variables have been previously reported in this context, most importantly gestational age (GA), but also patent ductus arteriosus (PDA) and duration of mechanical ventilation (MV) (1618). However, the evidence is weak and sometimes contradictory, mainly comprising small observational studies with highly heterogeneous study designs. Variables predictive of an infant's readiness to cease CPAP remain a topic of controversy among clinicians in neonatology (1622). Variables that are suitable for low-threshold use in common clinical settings appear desirable.

In this study we aimed to identify demographic and clinical variables predictive of early successful weaning in preterm infants <32 weeks GA that had been weaned off CPAP.

2 Methods

This was a single-center retrospective study. The study was reviewed by the local Ethics Committee of the Rhineland-Palatinate Medical Association Mainz, Germany, and a waiver of informed consent was granted [processing number 837.193.16 (10,512)]. This procedure is regulated by the state hospital law (§§ 36 and 37).

2.1 Participants

Infants with a GA of <32 0/7 weeks admitted to the neonatal intensive care unit (NICU) of the University Medical Center Mainz (UMC Mainz) in the 4-year period between April 2013 and March 2017 were eligible. UMC Mainz is a level III perinatal center. Infants were excluded if they: (1) did not require respiratory support, (2) did not receive CPAP after extubation, (3) received CPAP for less than six hours, (4) had a congenital malformation, or if they were: (5) out-born, (6) transferred to another unit before cessation of CPAP, (7) died before cessation of CPAP, or (8) if the medical record was not available at the time of the study. Infants were excluded if at least one criterion was met. By limiting the study population to preterm infants <32 0/7 weeks GA and applying exclusion criteria (1–4) we aimed on including preterm infants with RDS.

2.2 Weaning

CPAP was administered as per guideline using a starting positive end-expiratory pressure (PEEP) of 5 cm H2O that was escalated to 6–7 cm H2O if deemed necessary. PEEP reduction was commenced and conducted according to a standardized weaning protocol that had been implemented March 2013. The protocol provided for a systematic reduction of PEEP following a decision tree that was based on strict stability and failure criteria. According to the protocol, CPAP was discontinued at a PEEP of 4 cm H2O. For further details regarding the weaning protocol we refer to the source (23). Infants were defined as successfully weaned if they remained without positive pressure support for 72 h after cessation of CPAP therapy. The infants included in the study were categorized as (1) early successfully weaned (Early-W) and (2) delayed weaned (Delayed-W). (1) Early-W was defined as successful weaning on the first attempt of CPAP cessation. (2) Delayed-W was defined as successful weaning following two or more attempts of CPAP cessation.

2.3 Clinical practice for treatment of PDA

In clinical practice, hemodynamically relevant PDA was treated in mechanically ventilated preterm infants until extubation was possible. PDA was not treated in preterm infants receiving noninvasive respiratory support.

2.4 Demographic and clinical characteristics of the cohort

Data were collected including prenatal data, birth, infant characteristics at birth, therapeutic interventions, complications, feeding, growth and length of hospitalization.

2.5 Predictors of weaning success

Demographic and clinical variables potentially predictive of Early-W were pre-specified and selected based on the authors' clinical experience and literature review. Factors selected were: GA, MV duration, postmenstrual age (PMA) at CPAP cessation, weight at CPAP cessation, presence of PDA at CPAP cessation irrespective of prior PDA treatment, FiO2 at CPAP cessation, median respiratory rate (RR) during the 12 h prior to CPAP cessation, number of desaturations <80% during the 12 h prior to CPAP cessation.

2.6 Statistical analysis

The analysis sample excluded infants with missing data in any of the eight potential predictor variables. Descriptive statistics were therefore based on complete cases only. The descriptive analysis encompassed a group comparison between Early-W and Delayed-W with respect to demographic and clinical variables including the potential predictor variables. Characteristics were described by appropriate statistical parameters [e.g., absolute and relative frequencies for categorical variables, means and standard deviations (SD) for continuous variables].

To study the association between potential predictor variables and Early-W several binary logistic regression models were computed. First, eight univariable models with each potential predictor as independent variable were set up. Second, one multivariable full model with all eight potential predictors as independent variables was established. Third, to identify the best model to predict Early-W, while considering the risk for overfitting, predictor variables were selected from the full model by backward selection based on the Akaike information criterion (AIC) using the step function from the R stats package. Model results are reported as odds ratios (OR) with 95% confidence intervals (CI) and p values.

Performance of the full and the backwards selected model were studied by receiver operating characteristic (ROC) curves in the same sample of patients. The corresponding area under the curve (AUC) values were computed using cross-validation for more robust estimates and to further avoid overfitting. All analyses were exploratory and were carried out with R version 3.6.0.

3 Results

The study included 156 preterm infants. Data on the presence of a PDA at the time point of CPAP cessation was not available for 11 infants. Since the analysis sample excluded infants with missing data in any of the eight potential predictor variables, 145 infants were left for the analysis. Of these, 79 infants (54.5%) were Early-W and 66 (45.5%) were Delayed-W (see Figure 1). Early-W infants had higher GA and birth weight (BW), shorter duration of MV, received surfactant and postnatal steroids less often and had less complications related to prematurity. PMA at cessation of supplemental oxygen and CPAP were higher in Delayed-W. Table 1 summarizes the demographic and clinical characteristics of both groups. Estimates of potential predictor variables differed between groups (see Table 2).

Figure 1
www.frontiersin.org

Figure 1. Patient flowchart for preterm infants <32 weeks GA. Abbreviations: GA, gestational age; Early-W, early successfully weaned; Delayed-W, delayed weaned; CPAP, continuous positive airway pressure; PDA, patent ductus arteriosus.

Table 1
www.frontiersin.org

Table 1. Demographical and clinical characteristics of Early-W and Delayed-W group.

Table 2
www.frontiersin.org

Table 2. Potential predictor variables in Early-W and Delayed-W group at time point of first attempt of CPAP cessation.

Univariable logistic regression analysis of the eight potential predictor variables showed a significant association of six variables with Early-W. In multivariable logistic regression analysis including all eight potential predictor variables two variables remained significantly associated: GA and median RR in the 12 h prior to CPAP cessation. Backwards selection of the full model using the AIC singled out GA, PDA and median RR in the previous 12 h to be the best model to predict Early-W. (1) Each additional week of gestation increased the chance of Early-W by 66% (OR 1.66; 95% CI 1.39, 2.03; p < 0.001). (2) Presence of PDA at time point of CPAP cessation decreased the chance of Early-W by 59% (OR 0.41; 95% CI 0.16, 1.04; p 0.062). (3) Each 10 breaths/min increase of median RR over the 12 h prior to CPAP cessation decreased the chance of Early-W by 64% (OR 0.36; 95% CI 0.16, 0.74; p 0.008). Table 3 summarizes the logistic regression analysis for prediction of Early-W.

Table 3
www.frontiersin.org

Table 3. Logistic regression analysis of potential predictor variables for Early-W, n = 145.

Figure 2 compares the ROC curves with respective AUC of the full model (ROC-AUC 0.839) and backwards selected model (ROC-AUC 0.841).

Figure 2
www.frontiersin.org

Figure 2. Performance of full and backwards selected model (criterion: AIC) for prediction of Early-W by means of area under ROC curves. Abbreviations: AIC, Akaike information criterion; ROC, receiver operating characteristic.

4 Discussion

We identified one demographic and two clinical variables predictive of Early-W in preterm infants with a GA <32 weeks weaned off CPAP: GA, PDA and median RR in the 12 h prior to CPAP cessation. In a prediction model containing these three variables, overall model performance in predicting Early-W was high with an AUC of 0.841. The model showed comparable performance to the full model that included all potential predictor variables.

The predictive value of median RR in the 12 h prior to CPAP cessation is considered a novelty. For every 10 breaths/min increase in the median RR over the previous 12 h, there was a 64% decreased chance of successful weaning at the first attempt (OR 0.36; 95% CI 0.16, 0.74; p 0.008). It is noteworthy that the predictive value of median RR in the previous 12 h remained significant in the multivariable models despite the basic group differences between Early-W and Delayed-W: Delayed-W exhibited a lower GA, lower BW, longer duration of MV, more frequent surfactant applications and postnatal steroids, and a higher incidence of complications associated with preterm birth, particularly BPD. In the regression analysis OR and p-value for median RR in the previous 12 h remained rather stable, indicating a strong association that persisted, even after taking the other predicting variables into account. This is particularly noteworthy with regard to the similarly strong association of GA, suggesting relatively independent effects of RR and GA. RDS in the preterm infant is caused by surfactant deficiency and lung immaturity, leading to reduced lung compliance and inability to maintain FRC (2, 24, 25). Tachypnea represents one endogenous strategy in order to maintain FRC by initiating inspiration before end of expiration (24, 25). Thus, a lower median RR in the 12 h before CPAP cessation may correspond to the ability to maintain FRC autonomously, indicating advanced maturation of the respiratory system with enhanced lung compliance. As a consequence, infants with a lower median RR would be more likely to successfully cease CPAP at the first attempt. Accordingly, one could also hypothesize a higher median RR in the 12 h before CPAP cessation to indicate insufficient respiratory support and the need for a higher PEEP than 4 cm H2O in those infants. Recent evidence suggests that prolonging CPAP for 2 weeks in stable preterm infants increases lung volumes at 6 months corrected age (26). However, whether increasing PEEP would be beneficial in terms of decreasing RR (i.e., improving respiratory distress) in the short term and promoting lung growth in the long term is unknown. It should be noted that RR is a clinical parameter commonly employed in routine practice, making it practical for everyday application. There seems to be disagreement on how to set the RR threshold that marks weaning failure, considering how the applied thresholds range from 60 up to 80 breaths/min (3, 4, 6, 8, 23). With regard to the estimates for median RR in Delayed-W, possibly the thresholds guiding weaning decisions should be set in the somewhat lower range.

We conclude that RR must be given greater consideration when planning adequately powered future studies that prospectively investigate the optimal time point of CPAP cessation in preterm infants <32 weeks GA. Identification of cut-off values for clinical practice must follow and may be lower than commonly expected. RR might be suitable as a steering parameter in studies that investigate the optimal PEEP-level in preterm infants <32 weeks GA receiving CPAP.

We hypothesized that preterm infants <32 weeks GA with a PDA at time point of CPAP cessation would fail weaning more often than preterm infants without a PDA (16, 18, 21). While association of PDA with Early-W was significant in the univariable model, statistical significance did not persist in the multivariable models. It seems reasonable that PDA is associated to GA and RR, the main drivers of the multivariable models, with GA and RR taking precedence over the PDA. Though, it should be noted that OR and p-value of the PDA only change marginally in the course of the regression analysis, indicating a trend, closely missing the threshold of significance nevertheless. It is important to note, that in the regression analysis no distinction was made between hemodynamically relevant and non-relevant PDA. However, the description of the cohort indicates 50.0% medically treated PDAs in Delayed-W vs. 6.3% in Early-W (see Table 1). Hence, one could argue that distribution of hemodynamically relevant PDA was possibly not even among infants with a PDA in both groups, though we could not test this with the available data. It is interesting that the PDA does not get rejected when selecting the best model using the AIC. Model selection using the AIC is not based on p-values, rather the AIC aims for a balance between best model fit and least complexity (i.e., lowest number of variables) to avoid overfitting. Considering all of the above, we conclude that, when taking GA and RR into account to predict Early-W, information on presence or absence of PDA adds to the predictive capability of the model. Further sufficiently powered studies are needed to evaluate the differential effect of PDA in the context of important demographic and clinical variables on early successful CPAP weaning in preterm infants <32 weeks GA.

The predictive value of GA has already been recognized in previous studies (1618). Reasonably, prematurity contributes to an overall poorer health status, which particularly affects the respiratory system and leads to a higher incidence of BPD among other complications of prematurity. This results in a longer dependence on non-invasive respiratory support. Correspondingly, in our study Delayed-W had a significantly higher incidence of BPD than Early-W infants. Considering the above, individual weaning strategies tailored to GA appear beneficial. However, corresponding protocols are scarce in clinical practice (7, 27, 28).

There are limitations to our study. This was a single-center design and the sample size was relatively small. The design was retrospective, though weaning decisions during the study period were based on a standardized weaning protocol (23). The backwards selected model was trained and tested using the same patient cohort, carrying the risk of overfitting. To address this possible limitation while considering feasibility and limited sample size, AUC were calculated using cross-validation. The prevalence of Early-W was high (54.5%), therefore the calculated ORs may overestimate the relative risk. Study group distinction was based on the definition of being “successfully weaned” based on clinical stability criteria used at our study site (23). Variability of applied clinical stability criteria depending on study site is a known challenge, making our results less generalizable (3, 28). However, the observed prevalence of Early-W was comparable to similar studies (16, 17). With the inclusion of preterm infants up to a GA of <32 weeks, subgroup analysis for GA would have been desirable, yet not feasible due to limited sample size. Nevertheless, GA was included in the multivariable regression models.

5 Conclusion

In our study, median RR in the 12 h prior to CPAP cessation is independently predictive of Early-W. RR is a routine parameter commonly employed in clinical practice, making it practical for everyday application. RR must be given greater consideration when planning adequately powered future studies prospectively investigating the optimal time point of CPAP cessation in preterm infants. Further evidence is needed to explore the differential effect of PDA related to important demographic and clinical variables on early successful CPAP weaning in preterm infants.

Data availability statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethics statement

The study involving humans was approved by the Ethics Committee of the Rhineland-Palatinate Medical Association Mainz, Germany. The study was conducted in accordance with the local legislation and institutional requirements. The Ethics Committee waived the requirement of written informed consent for participation from the participants' legal guardians/next of kin because of the analysis of routine clinical data in anonymized form.

Author contributions

LB: Visualization, Writing – original draft, Writing – review & editing. CW: Conceptualization, Data curation, Investigation, Methodology, Visualization, Writing – review & editing, Validation. JS: Data curation, Formal analysis, Methodology, Software, Visualization, Writing – review & editing. BB: Writing – review & editing. M-HP-T: Writing – review & editing. ST: Writing – review & editing. JW: Writing – review & editing. EM: Conceptualization, Investigation, Methodology, Project administration, Supervision, Writing – review & editing. AK: Conceptualization, Investigation, Methodology, Project administration, Supervision, Validation, Writing – original draft, Writing – review & editing.

Funding

The author(s) declare that financial support was received for the research and/or publication of this article. The publication fee was covered by a publication fund of the University of Bern, Switzerland.

Acknowledgments

Part of the content of this manuscript appeared in the doctoral thesis of the author CW (29).

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declare that no Generative AI was used in the creation of this manuscript.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Abbreviations

Early-W, early successfully weaned; Delayed-W, delayed weaned.

References

1. Care of Preterm or Low Birthweight Infants Group. New World Health Organization recommendations for care of preterm or low birth weight infants: health policy. EClinicalMedicine. (2023) 63:102155. doi: 10.1016/j.eclinm.2023.102155

PubMed Abstract | Crossref Full Text | Google Scholar

2. Sweet DG, Carnielli VP, Greisen G, Hallman M, Klebermass-Schrehof K, Ozek E, et al. European consensus guidelines on the management of respiratory distress syndrome: 2022 update. Neonatology. (2023) 120(1):3–23. doi: 10.1159/000528914

PubMed Abstract | Crossref Full Text | Google Scholar

3. Abdel-Hady H, Shouman B, Nasef N. Weaning preterm infants from continuous positive airway pressure: evidence for best practice. World J Pediatr. (2015) 11(3):212–8. doi: 10.1007/s12519-015-0022-6

PubMed Abstract | Crossref Full Text | Google Scholar

4. Amatya S, Rastogi D, Bhutada A, Rastogi S. Weaning of nasal CPAP in preterm infants: who, when and how? A systematic review of the literature. World J Pediatr. (2015) 11(1):7–13. doi: 10.1007/s12519-014-0535-4

PubMed Abstract | Crossref Full Text | Google Scholar

5. Bamat N, Jensen EA, Kirpalani H. Duration of continuous positive airway pressure in premature infants. Semin Fetal Neonatal Med. (2016) 21(3):189–95. doi: 10.1016/j.siny.2016.02.005

PubMed Abstract | Crossref Full Text | Google Scholar

6. Duyka B, Beaullieu C, Khan AM. A comparison of methods of discontinuing nasal CPAP in premature infants <30 weeks gestation: a feasibility study. J Perinatol. (2021) 41(11):2658–63. doi: 10.1038/s41372-021-01200-9

PubMed Abstract | Crossref Full Text | Google Scholar

7. Kidszun A, Arnold C, Winter J, Whybra-Trümpler C, Mildenberger E. Weaning premature infants from nasal continuous positive airway pressure—current practice and scientific evidence. Klin Padiatr. (2017) 229(04):229–33. doi: 10.1055/s-0043-111890

PubMed Abstract | Crossref Full Text | Google Scholar

8. Todd DA, Wright A, Broom M, Chauhan M, Meskell S, Cameron C, et al. Methods of weaning preterm babies <30 weeks gestation off CPAP: a multicentre randomised controlled trial. Arch Dis Child Fetal Neonatal Ed. (2012) 97(4):F236–40. doi: 10.1136/adc.2011-300133

PubMed Abstract | Crossref Full Text | Google Scholar

9. Lam R, Schilling D, Scottoline B, Platteau A, Niederhausen M, Lund KC, et al. The effect of extended continuous positive airway pressure on changes in lung volumes in stable premature infants: a randomized controlled trial. J Pediatr. (2020) 217:66–72.e1. doi: 10.1016/j.jpeds.2019.07.074

PubMed Abstract | Crossref Full Text | Google Scholar

10. Mols G, Priebe HJ, Guttmann J. Alveolar recruitment in acute lung injury. Br J Anaesth. (2006) 96(2):156–66. doi: 10.1093/bja/aei299

PubMed Abstract | Crossref Full Text | Google Scholar

11. Osman M, Elsharkawy A, Abdel-Hady H. Assessment of pain during application of nasal-continuous positive airway pressure and heated, humidified high-flow nasal cannulae in preterm infants. J Perinatol. (2015) 35(4):263–7. doi: 10.1038/jp.2014.206

PubMed Abstract | Crossref Full Text | Google Scholar

12. Morley CJ, Davis PG, Doyle LW, Brion LP, Hascoet JM, Carlin JB. Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med. (2008) 358(7):700–8. doi: 10.1056/NEJMoa072788

PubMed Abstract | Crossref Full Text | Google Scholar

13. Schmidt F, Kalil Neto F, Radaelli G, Nunes ML. Effects of non-invasive respiratory support on sleep in preterm infants evaluated by actigraphy. Sleep Sci. (2021) 14(1):72–6. doi: 10.5935/1984-0063.20200035

PubMed Abstract | Crossref Full Text | Google Scholar

14. Collins CL, Barfield C, Horne RS, Davis PG. A comparison of nasal trauma in preterm infants extubated to either heated humidified high-flow nasal cannulae or nasal continuous positive airway pressure. Eur J Pediatr. (2014) 173(2):181–6. doi: 10.1007/s00431-013-2139-8

PubMed Abstract | Crossref Full Text | Google Scholar

15. Chen J, Lin Y, Du L, Kang M, Chi X, Wang Z, et al. The comparison of HHHFNC and NCPAP in extremely low-birth-weight preterm infants after extubation: a single-center randomized controlled trial. Front Pediatr. (2020) 8:250. doi: 10.3389/fped.2020.00250

PubMed Abstract | Crossref Full Text | Google Scholar

16. Yin Y, Broom M, Wright A, Hovey D, Abdel-Latif ME, Shadbolt B, et al. Ceasing cpap at standarD criteriA (CICADA): predicting a successful outcome. Eur J Pediatr. (2016) 175(1):81–7. doi: 10.1007/s00431-015-2603-8

PubMed Abstract | Crossref Full Text | Google Scholar

17. Mohsen N, Nasef N, Elkhouli M, Ghanem M, Dalby A, Yoon EW, et al. Predictors of successful trial off continuous positive airway pressure and high flow nasal cannula in preterm infants <30 weeks’ gestation: a retrospective study. Pediatr Pulmonol. (2022) 57(4):1000–7. doi: 10.1002/ppul.25827

PubMed Abstract | Crossref Full Text | Google Scholar

18. Nour BA, El-Rahman AMA, Hameed S, Mohsen N, Mohamed A, El-Bayoumi MA, et al. Lung and diaphragm ultrasound as predictors of successful weaning from nasal continuous positive airway pressure in preterm infants. Pediatr Pulmonol. (2024) 59(5):1428–37. doi: 10.1002/ppul.26933

PubMed Abstract | Crossref Full Text | Google Scholar

19. Nussbaum C, Lengauer M, Puchwein-Schwepcke AF, Weiss VBN, Spielberger B, Genzel-Boroviczény O. Noninvasive ventilation in preterm infants: factors influencing weaning decisions and the role of the Silverman-Andersen score. Children (Basel). (2022) 9(9):1292. doi: 10.3390/children9091292

PubMed Abstract | Crossref Full Text | Google Scholar

20. Heath Jeffery RC, Broom M, Shadbolt B, Todd DA. Ceasing cpap at standarD criteriA (CICADA): implementation improves neonatal outcomes. J Paediatr Child Health. (2016) 52(3):321–6. doi: 10.1111/jpc.13087

PubMed Abstract | Crossref Full Text | Google Scholar

21. Rastogi S, Rajasekhar H, Gupta A, Bhutada A, Rastogi D, Wung JT. Factors affecting the weaning from nasal CPAP in preterm neonates. Int J Pediatr. (2012) 2012:416073. doi: 10.1155/2012/416073

PubMed Abstract | Crossref Full Text | Google Scholar

22. Gentle SJ, Ambalavanan N, Carlo WA. Oxygen saturation histograms predict nasal continuous positive airway pressure-weaning success in preterm infants. Pediatr Res. (2020) 88(4):637–41. doi: 10.1038/s41390-020-0772-2

PubMed Abstract | Crossref Full Text | Google Scholar

23. Kidszun A, Plate M, Arnold C, Winter J, Gerhold-Ay A, Mildenberger E. Standardized weaning of infants <32 weeks of gestation from continuous positive airway pressure—a feasibility study. J Matern Fetal Neonatal Med. (2016) 29(19):3198–201. doi: 10.3109/14767058.2015.1118455

PubMed Abstract | Crossref Full Text | Google Scholar

24. Reuter S, Moser C, Baack M. Respiratory distress in the newborn. Pediatr Rev. (2014) 35(10):417–28; quiz 29. doi: 10.1542/pir.35-10-417

PubMed Abstract | Crossref Full Text | Google Scholar

25. Alexander P. 14—respiratory Physiology for intensivists. In: Ungerleider RM, Meliones JN, Nelson McMillan K, Cooper DS, Jacobs JP, editors. Critical Heart Disease in Infants and Children. 3rd ed. Philadelphia: Elsevier (2019). p. 134–49.e2.

Google Scholar

26. McEvoy CT, MacDonald KD, Go MA, Milner K, Harris J, Schilling D, et al. Extended continuous positive airway pressure in preterm infants increases lung growth at 6 months: a randomized controlled trial. Am J Respir Crit Care Med. (2025). doi: 10.1164/rccm.202411-2169OC

PubMed Abstract | Crossref Full Text | Google Scholar

27. Kakkilaya V, Tang A, Wagner S, Ridpath J, Ibrahim J, Brown LS, et al. Discontinuing nasal continuous positive airway pressure in infants ≤32 weeks of gestational age: a randomized control trial. J Pediatr. (2021) 230:93–9.e3. doi: 10.1016/j.jpeds.2020.10.045

PubMed Abstract | Crossref Full Text | Google Scholar

28. Healy H, Levesque B, Leeman KT, Vaidya R, Whitesel E, Chu S, et al. Neonatal respiratory care practice among level III and IV NICUs in new England. J Perinatol. (2024) 44(9):1291–9. doi: 10.1038/s41372-024-01926-2

PubMed Abstract | Crossref Full Text | Google Scholar

29. Walden C. Prädiktoren für eine frühe erfolgreiche CPAP-entwöhnung bei frühgeborenen <32 SSW. [doctoral thesis]. (2024). doi: 10.25358/openscience-10470

Crossref Full Text | Google Scholar

Keywords: preterm infant, respiratory distress, weaning, continuous positive airway pressure, respiratory rate, prediction

Citation: Bünte LM, Walden C, Schlecht J, Bubl B, Popa-Todirenchi M-H, Tippmann S, Winter J, Mildenberger E and Kidszun A (2025) Early successful weaning from continuous positive airway pressure in infants <32 weeks of gestation: predictors of success. Front. Pediatr. 13:1568891. doi: 10.3389/fped.2025.1568891

Received: 30 January 2025; Accepted: 10 March 2025;
Published: 3 April 2025.

Edited by:

Steven M. Donn, University of Michigan, United States

Reviewed by:

Ju Lee Oei, University of New South Wales, Australia
Mohammad Attar, University of Michigan, United States

Copyright: © 2025 Bünte, Walden, Schlecht, Bubl, Popa-Todirenchi, Tippmann, Winter, Mildenberger and Kidszun. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Lisa Marie Bünte, bGlzYS5idWVudGVAc3R1ZGVudHMudW5pYmUuY2g=

These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Research integrity at Frontiers

94% of researchers rate our articles as excellent or good

Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


Find out more